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Abstract
Background—The white coat effect (defined as the difference between blood pressure [BP] 
measurements taken at the physician’s office and those taken outside the office) is an important 
determinant of misdiagnosis of hypertension, but little is known about the mechanisms underlying 
this phenomenon. We tested the hypothesis that the white coat effect may be a conditioned 
response as opposed to a manifestation of general anxiety.
Methods—A total of 238 patients in a hypertension clinic wore ambulatory blood pressure 
monitors on 3 separate days 1 month apart. At each clinic visit, BP readings were manually 
triggered in the waiting area and the examination room (in the presence and absence of the 
physician) and were compared with the mercury sphygmomanometer readings taken by the 
physician in the examination room. Patients completed trait and state anxiety measures before and 
after each BP assessment.
Results—A total of 35% of the sample was normotensive, and 9%, 37%, and 19% had white 
coat, sustained, and masked hypertension, respectively. The diagnostic category was associated 
with the state anxiety measure (F3,237 = 6.4, P < .001) but not with the trait anxiety measure. 
Patients with white coat hypertension had significantly higher state anxiety scores (t = 2.67, P < .
01), with the greatest difference reported during the physician measurement. The same pattern was 
observed for BP changes, which generally paralleled the changes in state anxiety (t = 4.86, P < .
002 for systolic BP; t = 3.51, P < .002 for diastolic BP).
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Conclusions—These findings support our hypothesis that the white coat effect is a conditioned 
response. The BP measurements taken by physicians appear to exacerbate the white coat effect 
more than other means. This problem could be addressed with uniform use of automated BP 
devices in office settings.
Physicians’ offices are the venues in which most interactions with patients occur, including 
the measurement of blood pressure (BP) and the delivery of diagnoses. The surroundings in 
which these transactions occur hold great emotional import for some patients, who may 
have, at one time or another, received frightening information about their health, increasing 
their anxiety and BP during subsequent visits and hence biasing the assessment of their 
hypertension status. The introduction of ambulatory BP monitoring has made it clear that the 
traditionally measured office BP is usually somewhat higher than the pressure during the rest 
of the day, particularly in patients who have been diagnosed with hypertension or labeled as 
being hypertensive.1 It is also well established that ambulatory BP predicts cardiovascular 
events better than office BP.2–4 If the office BP readings are in the hypertensive range and 
the ambulatory BP is normal, this leads to a diagnosis of white coat hypertension, which 
occurs in 10% to 20% of hypertensive patients.5,6 Although controversial, this condition 
may be considered benign because the risk of cardiovascular disease in this group of patients 
is comparable to that in normotensive patients,5,7 and thus antihypertensive drug treatment is 
generally considered to be unnecessary. The white coat effect (defined as the difference 
between BP measurements taken at the physician’s office and those taken outside the office, 
using ambulatory monitoring) is, however, also strongly positive in most hypertensive 
patients and tends to increase with age.8 In contrast, in persons whose office BP is normal, 
the white coat effect is typically absent or negative,8 which may be explained by the fact that 
physical and mental activities are higher during normal daily activities than during office BP 
measurement. Alternatively, it suggests that, for some persons, the physician’s office has not 
become a stimulus cue for anxiety or, furthermore, may even represent a relaxing situation. 
Either or both of these possibilities may account for the phenomenon of masked 
hypertension (elevated ambulatory BP and normal office BP).9 Masked hypertension is 
estimated to occur in 10% to 20% of the general population9,10 (in contrast to white coat 
hypertension, which has a similar prevalence but only within the diagnosed hypertensive 
population, a much smaller group). Masked hypertension has been associated with target 
organ damage11 and elevated cardiovascular risk.9 However, it is usually not detected or 
treated. Because of the public health significance and treatment implications of these 
diagnostic categories, it is important to understand the underlying mechanisms that may lead 
to disagreements between in-office and out-of-office BP measurements.
The focus of the present study is on the mechanisms underlying the white coat effect, which 
is an important determinant of misdiagnosis. Thus, the purpose of this study is to investigate 
the causes of the disagreement observed between office and ambulatory BP measures.
Two competing theories, related to patients’ anxiety levels in the physician’s office, have 
been put forth to explain the occurrence of white coat hypertension and the white coat effect. 
First, the generalized anxiety theory asserts that patients with a general, stable (ie, “trait”) 
tendency to be anxious are more likely to be diagnosed with white coat hypertension.12 
Several studies,12–15 however, have failed to find a relationship between trait measures of 
Ogedegbe et al. Page 2





















anxiety and office BP. Second, the classical (or respondent) conditioning model provides a 
useful alternative model by which to understand the cause of the elevated office BP and the 
attendant risk of misdiagnosis. A classical conditioning model suggests that patients with 
white coat hypertension have been exposed to unpleasant experiences, such as unwelcome 
medical diagnoses and/or painful medical procedures (in the classical conditioning model, 
these are referred to as “unconditioned stimuli”), in 1 or more physicians’ offices, which 
may lead to transient anxiety and a concomitant BP increase (referred to as the 
“unconditioned response”).16–18 With repeated exposure, the cues associated with the 
unconditioned stimuli, for example, the physician’s white coat and the appearance of the 
examination room (which tends to be similar across medical offices), are all potential 
conditioned stimuli to the extent that they acquire the power to themselves elicit anxiety and 
elevated BP. Figure 1 shows the hypothesized classical conditioning process that may lead to 
white coat hypertension. An interesting example of conditioning is seen in patients with 
cancer undergoing chemotherapy. One consequence of this therapy is nausea, an 
unconditioned response. Several studies19 have reported that many such patients experience 
nausea in the period preceding their therapy, indicating that the nausea has become a 
conditioned response. It is only under specific conditions that the nausea occurs, however (in 
this case, represented by temporality and, possibly, the clinic milieu). We suggest that the 
classical conditioning model, compared with the general anxiety theory, provides a more 
useful explanation of the white coat effect.
Although both hypotheses specify anxiety as the cause of BP elevation in the physician’s 
office, the general anxiety hypothesis assumes that persons with higher trait anxiety would 
be expected to have elevated BP regardless of the setting, that is, both inside and outside the 
physician’s office. The conditioning hypothesis, in contrast, posits that the anxiety response 
is specific to a particular set of circumstances and thus predicts that BP measurements taken 
only under those circumstances will be elevated. If correct, this theory suggests that the 
reason that past studies have failed to find an association between anxiety and white coat 
hypertension is that they have failed to measure the anxiety that occurs in the specific 
situation in which the BP measurements are being taken.
A means of testing the conditioning vs anxiety hypotheses is provided by the duration of the 
BP elevation after the departure of the physician (the conditioned stimulus) from the 
examination room. A conditioning explanation can readily account for rapid BP changes as a 
function of a change in the stimulus conditions (eg, moving from a waiting room into an 
examination room); however, a general anxiety explanation cannot. If trait anxiety were the 
cause, the elevated level of anxiety throughout the situation would dominate compared with 
marked increases and decreases when moving from neutral to conditioned circumstances. 




A total of 277 patients completed the study. Eligibility criteria included age of 18 to 80 
years; willingness of the patient, with his/her physician’s permission, to stop taking 
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antihypertensive medication for the 8-week study duration; no previous cardiovascular 
morbid event; no major medical problems other than hypertension; body mass index 
(calculated as weight in kilograms divided by height in meters squared) below 32.5; and 
English speaking. For study purposes, a diagnosis of hypertension was established only after 
participants had undergone 36-hour ambulatory BP monitoring. Based on office and 
ambulatory measurements, patients were categorized as normotensive (35%), sustained 
hypertensive (37%), white coat hypertensive (9%), or masked hypertensive (19%). Figure 2 
shows the algorithm by which hypertension status was diagnosed, and Table 1 gives the 
sample’s demographic characteristics. The sample was drawn from physician referrals to the 
Weill Cornell Hypertension Center of New York Presbyterian Hospital and through media 
advertisements. Eligible patients were referred into the study by 3 participating physicians 
(T.G.P. and others) at the center, and the study procedures were approved by the hospital’s 
institutional review board.
PROCEDURE
An initial recruitment visit was followed by 3 assessments that lasted for 2 days each, 
occurring at 1-month intervals. Figure 3 shows the study timeline and procedures.
Day 1 Visit
The patient was fitted with an arm cuff for an ambulatory BP monitor (model 90207; 
Spacelabs, Redmond, Washington). This monitor has been previously validated, satisfying 
the British Hypertension Society protocol.20 During the fitting, 3 calibration readings were 
taken in accordance with the British Hypertension Society guidelines. Next, a research 
assistant took 3 BP measurements using a mercury sphygmomanometer according to the 
American Heart Association guidelines.21 These measurements provided the means to 
evaluate their comparability with manually triggered ambulatory BP measurements. The 
patient was told that he/she would wear the monitor until bedtime the following day, at 
which point the patient would remove the arm cuff. Blood pressure measurements were 
taken every 15 minutes until 10 PM and every hour between 10 PM and 6 AM the next morning, 
after which the sampling interval reverted to 15 minutes.
Day 2 Visit
The patient (still wearing the ambulatory monitor) was met by the research assistant at the 
clinic waiting area, where he/she was asked to sit and relax. After a 5-minute rest, the 
research assistant assessed anxiety, using the Brief Symptom Inventory, Spielberger Trait 
Anxiety Scale, and the Taylor Manifest Anxiety Scale (trait measures; taken only once). A 
single-item measure of state anxiety, using a visual analog scale, was taken at several points 
during the protocol. The research assistant then manually triggered 2 BP measurements 
using the ambulatory monitor 2minutes apart. State anxiety was then assessed a second time. 
Figure 3 shows the ordering of the procedures.
Ten to 15 minutes later, patients were taken to the examination room, where the research 
assistant assessed their state anxiety a third time and then triggered 2 more BP 
measurements, using the ambulatory monitor, separated by 2 minutes. The research assistant 
then assessed state anxiety a fourth time. Within 5 minutes of the patient being seated in the 
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examination room, the physician entered the room. State anxiety was assessed a fifth time; 
the physician then took 3 BP measurements using a mercury column sphygmomanometer, 
and, with the physician still present, the patient’s anxiety was assessed a sixth time. The 
physician left the room, and the seventh anxiety assessment was administered. After this, 2 
BP measurements were taken by manually triggering the ambulatory monitor followed by a 
final (eighth) anxiety assessment. The patient then left the hypertension center still wearing 
the ambulatory monitor.
DATA REDUCTION
The BP and state anxiety scores were averaged for the 3 assessments. When data were 
missing on any given variable at 1 of the assessments, the remaining data were averaged; 
when data were missing at 2 of the assessments, the values from the remaining session were 
used as the score. A list-wise deletion procedure was used in which patients with missing 
data on more than 1 key variable were excluded from the analysis. Awake ambulatory BP 
was based on diary entries, which provided bedtime and awake-time information. Manually 
triggered ambulatory BP measurements were excluded from the calculation of a wake 
ambulatory means.
STATISTICAL ANALYSES
Analysis of covariance was used to estimate the significance of the effects of a patient’s 
diagnostic category on BP and anxiety, and the Tukey highly significant difference post hoc 
test was used to determine the significance of differences among groups when the omnibus 
test result was statistically significant. The Mauchly test of sphericity was used when 
repeated-measures designs tested more than 2 conditions, and the Green-house-Geisser 
correction to degrees of freedom was used when the Mauchly test result was statistically 
significant. t Tests were used to compare mean change scores. Analyses were performed 
using a commercially available software program (SPSS, version 11).22 As mentioned 
previously, the algorithm by which patients were assigned to 1 of the 4 diagnostic categories 
is shown in Figure 2.
RESULTS
COMPARISON OF AMBULATORY AND SPHYGMOMANOMETER BP MEASUREMENTS
The physician-taken BP measurements were made using a mercury sphygmomanometer 
because this is the standard basis for a diagnosis of hypertension, according to the American 
Heart Association criteria. However, the remaining BP measurements were taken by the 
ambulatory monitor. To assess the comparability between measurements taken using the 
different devices, we compared the measurements taken in the laboratory on day 1 using a 
mercury sphygmomanometer and the manually triggered ambulatory BP readings. The 
average systolic/diastolic BP using the manometer was 129.3/77.8 mm Hg compared with 
129.6/77.9 mm Hg using the ambulatory monitor. Pearson correlations were 0.95 (systolic) 
and 0.92 (diastolic) (P < .001 for both). These results suggest that a valid comparison may 
be made between the measurements using the 2 methods.
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COMPARISON OF ANXIETY MEASURES BY DIAGNOSIS
Table 2 gives the scores for the various anxiety measures broken down by diagnostic 
category. The final column shows the mean state anxiety ratings made during the day 2 visit. 
As with previous studies, diagnostic category was not associated with the trait measures of 
anxiety. As predicted, the only measure on which diagnosis did have an effect was the state 
measure (F3,237 = 6.4, P < .001). A planned contrast indicated that patients in the white coat 
hypertension group had significantly higher state anxiety scores than any of the other 3 
categories (t = 2.67, P < .01).
To further explore the effect of diagnosis on the state anxiety measures, we examined the 
pattern of the scores across the session (Figure 4). A repeated-measures analysis of 
covariance, controlling for age and sex, showed that the interaction between the 
circumstance under which the measurement was made (ie, in the waiting room, in the 
examination room, physician absent or present) and the diagnostic category had a 
statistically significant effect on state anxiety (F15.4,1083 = 1.69, P < .05). The only other 
statistically significant outcome was the main effect of diagnosis (F3,228 = 5.15, P < .01).
We next examined the 2 state anxiety scores taken when the physician entered and exited the 
examination room. Planned contrasts (controlling for age and sex) were used to examine the 
differences in the changes as a function of diagnosis. The comparisons showed that the white 
coat hypertension group had the largest increase in anxiety compared with the other 3 
diagnostic categories immediately after the physician took their BP measurements (t = 3.15, 
P = .002).
COMPARISON OF BP MEASUREMENTS BY DIAGNOSIS
Figure 5 shows the mean systolic BP (the diastolic BP pattern was similar) for each of the 
diagnostic categories taken on day 1 and at the 4 time points in the clinic on day 2. 
Relatively little variability was seen in the measurement means for the essential hypertension 
patient group, and the BP of the normotensive patients and masked hypertensive patients 
decreased when the physician entered the room. Only the white coat hypertension group 
showed an increase in BP in the presence of the physician. We used analysis of covariance to 
examine the significance of the differences, with the 4 BP measures taken in the clinic as a 
repeated-measures factor and diagnosis as a between-patient factor. Age and sex were 
included as covariates. The analysis showed that for systolic and diastolic pressure the 
interaction between setting and diagnosis was statistically significant (F6.4,490.8 = 6.58, P < .
001 for systolic BP and F6.9,532.4 = 3.24, P < .01 for diastolic BP).
To further explore the interaction, we examined the BP changes among the measurements 
taken just before the physician entered the examination room, the measurements taken by 
the physician, and the measurements taken just after the physician left the room. A planned 
contrast (controlling for age and sex) was used to examine the differences in the BP changes 
as a function of diagnosis. The comparisons showed that the white coat hypertension group 
had the largest increase in both systolic and diastolic BP compared with the other 3 
diagnostic categories between the readings taken before and after the physician had entered 
the room (t = 4.86, P < .001 for systolic BP and t = 3.51, P = .002 for diastolic BP). A 
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similar pattern was observed for the BP changes that occurred when the physician exited the 
examination room. The planned contrast confirmed that the white coat hypertension group 
had the largest decrease in BP compared with the other 3 diagnostic categories associated 
with the physician exiting the room (t = 4.57, P < .001 for systolic BP and t = 4.07, P = .001 
for diastolic BP).
COMMENT
The results provide support for the hypothesis that anxiety and/or BP is a conditioned 
response to a specific set of stimuli, notably, the presence of the physician. Our results 
suggest that white coat hypertension is not a result of trait anxiety; on both state and trait 
anxiety measures, as in previous studies, persons diagnosed with white coat hypertension 
scored no higher than persons in any of the other diagnostic categories. If anxiety is 
conditioned, however, one would not expect to observe such differences. Rather, we would 
expect that the differences are only evident when assessed under the specific stimulus 
conditions that occasion the response. This was clearly seen in the differences in the state 
anxiety measures administered during the clinic assessment. Patients with white coat 
hypertension exhibited greater anxiety, on average, than those in any of the other diagnostic 
categories, were highest at every point during the clinic assessment of anxiety (Figure 4), 
and had a significantly greater elevation in anxiety when their BP was measured by the 
physician. The BP data followed a similar pattern. When the physician entered the 
examination room, patients with essential hypertension showed little change when the 
physician took their BP, and the BP of normotensive and masked hypertensive patients 
tended to decrease somewhat under this condition. As with the anxiety data, however, 
patients with white coat hypertension exhibited a substantial BP increase when the physician 
took the measurements.
Interestingly, the data in the present study suggest that patients with masked hypertension 
responded much like true normotensive patients in terms of both their anxiety in the 
examination room and their BP responses to the physician. We speculate that 1 source of the 
unconditioned anxiety is the hypertension diagnosis itself. This may suggest that the absence 
of a diagnosis of hypertension fails to produce the conditioned responses observed in those 
with white coat hypertension. Eighteen years ago, Rostrup et al23 showed that individuals 
who were hypertensive at screening but had never been diagnosed with hypertension, once 
given a diagnosis of hypertension, had substantially elevated BP on their next clinic visit 
compared with a randomly assigned group who were not told that their BP was high. These 
data suggest that simply being labeled as “hypertensive” may set the stage for the 
conditioning processes that we hypothesize are occurring here. Thus, our data indicate that 
the 2 “unlabeled” groups (normotensive and masked hypertensive patients) exhibit the 
lowest levels of anxiety compared with patients with true and white coat hypertension who 
have been given diagnostic labels.
The purpose of the study was to test the hypothesis that the white coat effect may be a 
conditioned response as opposed to a manifestation of general anxiety. We have shown 
previously that one of the major determinants of white coat effect is having been diagnosed 
with hypertension,1 which is consistent with a conditioned response. The data presented 
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herein also support this mechanism since the patients with white coat hypertension did not 
differ from the other groups in terms of the trait measures of anxiety but differed markedly 
in the levels of anxiety reported in the medical setting, with the greatest difference reported 
during the physician measurement. The same pattern was observed with the BP changes, 
which generally paralleled the changes in anxiety.
CONCLUSION
White coat hypertension is an important clinical problem given its potential to result in 
misdiagnosis and possibly inappropriate drug treatment. Although ambulatory and home BP 
measurements are more accurate and predictive of target organ damage, physicians’ office 
measurements continue to be the criterion standard. That being the case, the sources of 
measurement error that occur in the office setting remain an impediment to the accurate 
diagnosis and treatment of hypertension. Data from several studies show that who takes the 
BP and how it is taken (ie, by a person or an automated device) have a substantial effect on 
the measurement.24 Our findings indicate that measurements taken by physicians appear to 
exacerbate the white coat effect more than other means. We suggest that one way of 
addressing this problem is to modify the method by which BP is measured in the office 
setting given the wide availability of reliable and validated automated BP monitors that are 
suitable for both office and home use. Similarly, home BP monitoring has been shown to 
predict target organ damage as well as (or better than) ambulatory monitoring25 and, thus, is 
superior in this regard to traditional office measurements. Thus, BP taken by an automatic 
device, while the patient is alone in the physician’s office, may provide the best means of 
avoiding a hypertension misdiagnosis.
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Schematic drawing of the hypothesized conditioning process that may lead to white coat 
hypertension. Upward arrow indicates increase.
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Diagnostic categories and associated target organ damage, based on the joint assessment of 
clinic and ambulatory blood pressure (BP).
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Study timeline. BP indicates blood pressure.
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Mean visual analog scale scores before and after the physician’s entrance to the examination 
room for the 4 diagnostic categories. BP indicates blood pressure.
Ogedegbe et al. Page 13






















Mean systolic blood pressure (BP) before and after the physician’s entrance to the 
examination room and before and after the physician’s exit from the examination room for 
the 4 diagnostic categories. Error bars indicate standard errors.
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Table 1
Demographic Characteristics of the Diagnostic Groupsa
Characteristic Normotensive White Coat Hypertensive Sustained Hypertensive Masked Hypertensive
Age, mean (SD), yb 45.9 (13) (n = 85) 56.3 (14) (n = 20) 56.0 (13) (n = 90) 52.2 (17) (n = 43)
BMI, mean (SD) 26.7 (6) (n = 78) 27.6 (6) (n = 19) 27.1 (5) (n = 87) 27.0 (5) (n = 40)
Race, No. (%)
White, non-Hispanic 38 (45) 15 (75) 58 (64) 24 (56)
  White, Hispanic 8 (9) 1 (5) 6 (7) 2 (5)
  Black, non-Hispanic 25 (29) 3 (15) 14 (15) 11 (26)
  Black, Hispanic 3 (4) 0 3 (3) 2 (5)
  Asian/Indian/Pacific Islander 6 (7) 1 (5) 4 (4) 3 (7)
  Native American/Alaskan Native 1 (1) 0 0 0
  Other 4 (5) 0 6 (7) 1 (2)
  Total 85 (100) 20 (100) 91 (100) 43 (100)
Female, No. (%)c 52 (62) 14 (70) 37 (41) 20 (46)
Abbreviation: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared).
a
Data on age missing from 3 study participants; data on BMI missing from 2 study participants.
bP < .001 (these variables are included as covariates in the analyses).
cP < .05.
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Table 2










Normotension 3.3 (3.3) 19.6 (9.0) 7.1 (4.4) 14.5 (15.6)
White coat hypertension 2.5 (2.0) 16.2 (9.2) 5.9 (4.5) 30.6 (25.4)
Sustained hypertension 3.2 (3.4) 18.6 (9.6) 6.7 (4.5) 24.5 (23.3)
Masked hypertension 2.1 (1.8) 15.6 (8.9) 6.0 (3.6) 15.9 (15.0)
aP < .001.
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